UPC Analytics
ENDE
Overview · Filed: Dec 31, 2024

UPC_CFI_846/2024

REENGINEERING MRNA PRIMARY STRUCTURE FOR ENHANCED PROTEIN PRODUCTION

InfringementMain Infringement ActionMunich LDInfringementInterim Phase
OverviewDecisionsDocumentsTimeline
Parties

Claimants

  • Promosome LLC
Reps: Georg A. Rauh (Vossius & Partner Patentanwälte Rechtsanwälte mbB)

Respondents

  • BioNTech SE
  • BioNTech Manufacturing GmbH
  • BioNTech Manufacturing Marburg GmbH
  • BioNTech Innovative Manufacturing Services GmbH
  • BioNTech Europe GmbH
  • Pfizer Manufacturing Belgium NV
  • Pfizer SAS
  • Pfizer AB
  • Pfizer, Inc.
Reps: Christine Kanz (HOYNG ROKH MONEGIER); Tobias J. Hessel (Clifford Chance Partnerschaft mbB)
Judges
  • Daniel Voss
  • Andras Kupecz
  • Georg Werner
  • Martin Schmidt
Patents
  • EP2401365
  • EP 2 401 365
CPC codes: C12P21/00, C12N15/111, C12P21/02, C12N15/63, C12N15/67, C12N2310/141, C12N2320/53, C12N2320/50

Technology area: Biotech · mRNA

Sector: Biotechnology

Outcome
Procedural onlyProcedural only (no substantive ruling yet)
Filed: Dec 31, 2024
First decided: —
Language: English
Open on UPC Registry